​

H&R GmbH & Co. KGaA

XTRA:2HRA Stock Report

Market Cap: €184.6m

H&R GmbH KGaA (2HRA) Stock Overview

Engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts in Europe, Africa, Asia, and internationally. More details

2HRA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends3/6

Rewards

Trading at 3.2% below our estimate of its fair value

Risk Analysis

Volatile share price over the past 3 months compared to the German market

Unstable dividend track record


2HRA Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

H&R GmbH & Co. KGaA Competitors

Price History & Performance

Summary of share price highs, lows and changes for H&R GmbH KGaA
Historical stock prices
Current Share Price€4.96
52 Week High€5.04
52 Week Low€3.23
Beta0.77
1 Month Change-0.20%
3 Month Change32.62%
1 Year Change3.33%
3 Year Change-17.61%
5 Year Change-15.65%
Change since IPO-32.42%

Recent News & Updates

There's No Escaping H&R GmbH & Co. KGaA's (ETR:2HRA) Muted Earnings Despite A 33% Share Price Rise

May 17
There's No Escaping H&R GmbH & Co. KGaA's (ETR:2HRA) Muted Earnings Despite A 33% Share Price Rise

Recent updates

There's No Escaping H&R GmbH & Co. KGaA's (ETR:2HRA) Muted Earnings Despite A 33% Share Price Rise

May 17
There's No Escaping H&R GmbH & Co. KGaA's (ETR:2HRA) Muted Earnings Despite A 33% Share Price Rise

Why Investors Shouldn't Be Surprised By H&R GmbH & Co. KGaA's (ETR:2HRA) 25% Share Price Surge

Mar 17
Why Investors Shouldn't Be Surprised By H&R GmbH & Co. KGaA's (ETR:2HRA) 25% Share Price Surge

This H&R GmbH & Co. KGaA (ETR:2HRA) Analyst Is Way More Bearish Than They Used To Be

Oct 16
This H&R GmbH & Co. KGaA (ETR:2HRA) Analyst Is Way More Bearish Than They Used To Be

Returns On Capital At H&R GmbH KGaA (ETR:2HRA) Have Stalled

Jul 24
Returns On Capital At H&R GmbH KGaA (ETR:2HRA) Have Stalled

H&R GmbH KGaA (ETR:2HRA) Is Paying Out A Dividend Of €0.10

Apr 26
H&R GmbH KGaA (ETR:2HRA) Is Paying Out A Dividend Of €0.10

Why H&R GmbH & Co. KGaA (ETR:2HRA) Could Be Worth Watching

Dec 21
Why H&R GmbH & Co. KGaA (ETR:2HRA) Could Be Worth Watching

Is H&R GmbH KGaA (ETR:2HRA) Using Too Much Debt?

Apr 29
Is H&R GmbH KGaA (ETR:2HRA) Using Too Much Debt?

H&R GmbH KGaA (ETR:2HRA) Has More To Do To Multiply In Value Going Forward

Aug 09
H&R GmbH KGaA (ETR:2HRA) Has More To Do To Multiply In Value Going Forward

These 4 Measures Indicate That H&R GmbH KGaA (ETR:2HRA) Is Using Debt Extensively

Jul 19
These 4 Measures Indicate That H&R GmbH KGaA (ETR:2HRA) Is Using Debt Extensively

H&R GmbH KGaA (ETR:2HRA) Has A Somewhat Strained Balance Sheet

Mar 22
H&R GmbH KGaA (ETR:2HRA) Has A Somewhat Strained Balance Sheet

What Does H&R GmbH & Co. KGaA's (ETR:2HRA) Share Price Indicate?

Feb 22
What Does H&R GmbH & Co. KGaA's (ETR:2HRA) Share Price Indicate?

H&R GmbH KGaA (ETR:2HRA) Takes On Some Risk With Its Use Of Debt

Nov 27
H&R GmbH KGaA (ETR:2HRA) Takes On Some Risk With Its Use Of Debt

Is H&R GmbH KGaA (ETR:2HRA) A Risky Investment?

Jul 22
Is H&R GmbH KGaA (ETR:2HRA) A Risky Investment?

The Returns On Capital At H&R GmbH KGaA (ETR:2HRA) Don't Inspire Confidence

May 26
The Returns On Capital At H&R GmbH KGaA (ETR:2HRA) Don't Inspire Confidence

H&R GmbH & Co. KGaA (ETR:2HRA) Shares Could Be 40% Below Their Intrinsic Value Estimate

Apr 29
H&R GmbH & Co. KGaA (ETR:2HRA) Shares Could Be 40% Below Their Intrinsic Value Estimate

H&R GmbH KGaA (ETR:2HRA) Has Debt But No Earnings; Should You Worry?

Mar 28
H&R GmbH KGaA (ETR:2HRA) Has Debt But No Earnings; Should You Worry?

H&R GmbH KGaA's (ETR:2HRA) Shareholders Are Down 57% On Their Shares

Feb 04
H&R GmbH KGaA's (ETR:2HRA) Shareholders Are Down 57% On Their Shares

H&R GmbH KGaA (ETR:2HRA) Has Debt But No Earnings; Should You Worry?

Dec 13
H&R GmbH KGaA (ETR:2HRA) Has Debt But No Earnings; Should You Worry?

Shareholder Returns

2HRADE ChemicalsDE Market
7D0%0.4%-0.5%
1Y3.3%-2.5%17.0%

Return vs Industry: 2HRA exceeded the German Chemicals industry which returned -3% over the past year.

Return vs Market: 2HRA underperformed the German Market which returned 16.7% over the past year.

Price Volatility

Is 2HRA's price volatile compared to industry and market?
2HRA volatility
2HRA Average Weekly Movement9.2%
Chemicals Industry Average Movement4.4%
Market Average Movement5.2%
10% most volatile stocks in DE Market11.8%
10% least volatile stocks in DE Market2.6%

Stable Share Price: 2HRA's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 2HRA's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
20161,714Niels Hansenwww.hur.com

H&R GmbH & Co. KGaA engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts in Europe, Africa, Asia, and internationally. It operates in three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other crude oil-based specialty products, as well as by-products, such as feedstocks and bunker fuels.

H&R GmbH & Co. KGaA Fundamentals Summary

How do H&R GmbH KGaA's earnings and revenue compare to its market cap?
2HRA fundamental statistics
Market cap€184.62m
Earnings (TTM)€11.05m
Revenue (TTM)€1.36b
16.7x
P/E Ratio
0.1x
P/S Ratio

Is 2HRA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2HRA income statement (TTM)
Revenue€1.36b
Cost of Revenue€1.05b
Gross Profit€308.39m
Other Expenses€297.35m
Earnings€11.05m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Aug 15, 2025

Earnings per share (EPS)0.30
Gross Margin22.72%
Net Profit Margin0.81%
Debt/Equity Ratio48.1%

How did 2HRA perform over the long term?

See historical performance and comparison

Dividends

2.0%
Current Dividend Yield
34%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/15 06:43
End of Day Share Price 2025/07/15 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

H&R GmbH & Co. KGaA is covered by 15 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Konstantin WiechertBaader Helvea Equity Research
Christian ObstBaader Helvea Equity Research
Knut WollerBaader Helvea Equity Research